Outcome of patients (pts) with brain metastases (BMs) from HER2-positive breast cancer (BC) treated with lapatinib plus capecitabine (LC).Giulio Metro, Stefania Gori, Lucia Stocchi et al.|Journal of Clinical Oncology|2010Cited by 1